109 related articles for article (PubMed ID: 8072722)
1. Influence of long-term erythropoietin treatment on insulin, glucagon, pancreatic polypeptide, and gastrin secretion in haemodialysed patients.
Kokot F; Nieszporek T; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Nephrol Dial Transplant; 1994; 9 Suppl 3():35-9. PubMed ID: 8072722
[TBL] [Abstract][Full Text] [Related]
2. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
[TBL] [Abstract][Full Text] [Related]
3. [Influence of long-term treatment with human recombinant erythropoietin on secretion of hormones regulating carbohydrate metabolism in hemodialyzed patients with chronic uremia].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Pol Arch Med Wewn; 1995 Dec; 94(6):488-94. PubMed ID: 8618811
[TBL] [Abstract][Full Text] [Related]
4. Influence of long-term erythropoietin therapy on endocrine abnormalities in haemodialyzed patients.
Kokot F; Wiecek A; Schmidt-Gayk H; Marcinkowski W; Nieszporek T; Rudka R; Trembecki J
Przegl Lek; 1992; 49(1-2):43-9. PubMed ID: 1455006
[TBL] [Abstract][Full Text] [Related]
5. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
[TBL] [Abstract][Full Text] [Related]
6. The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin.
Tuzcu A; Bahceci M; Yilmaz E; Bahceci S; Tuzcu S
Horm Metab Res; 2004 Oct; 36(10):716-20. PubMed ID: 15523598
[TBL] [Abstract][Full Text] [Related]
7. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients.
Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J
Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958
[TBL] [Abstract][Full Text] [Related]
8. [Does long-term human recombinant erythropoietin (rHuEPO) influence secretion of hormones regulating volume and pressure of arterial blood?].
Rudka R; Kokot F; Wiecek A; Marcinkowski W; Trembecki J
Pol Arch Med Wewn; 1994 Aug; 92(2):154-61. PubMed ID: 7800584
[TBL] [Abstract][Full Text] [Related]
9. Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients.
Kokot F; Wiecek A; Mesjasz J; Adamczak M; Spiechowicz U
Nephrol Dial Transplant; 1998 May; 13(5):1200-5. PubMed ID: 9623554
[TBL] [Abstract][Full Text] [Related]
10. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
[TBL] [Abstract][Full Text] [Related]
12. High circulating levels of glucagon and gastrin in anephric subjects.
Trimble ER; Buchanan KD
N Z Med J; 1976 May; 83(564):357-60. PubMed ID: 785321
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
[TBL] [Abstract][Full Text] [Related]
14. Effects of erythropoietin on glucose tolerance in hemodialysis patients.
Chagnac A; Weinstein T; Zevin D; Korzets A; Hirsh J; Gafter U; Levi J
Clin Nephrol; 1994 Dec; 42(6):398-400. PubMed ID: 7882604
[TBL] [Abstract][Full Text] [Related]
15. [Improvement of sexual function in hemodialyzed male patients with chronic renal failure treated with erythropoietin (rHuEPO)].
Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
Przegl Lek; 1995; 52(9):462-6. PubMed ID: 8834648
[TBL] [Abstract][Full Text] [Related]
16. [Influence of long-term erythropoietin (rHuEPO) therapy on the function of the pituitary-gonadal axis in hemodialyzed male patients with end stage renal failure].
Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
Pol Arch Med Wewn; 1995 Aug; 94(2):144-52. PubMed ID: 8596749
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
18. [Abnormal increase in pancreatic polypeptide in the secretin-provocation test: hypoglycemia-induced?].
Wirth HP; Eberle C; Gautschi K; Meyenberger C; Ammann R
Schweiz Med Wochenschr; 1995 Apr; 125(15):735-9. PubMed ID: 7740287
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin.
Bárány P; Pettersson E; Konarski-Svensson JK
Nephrol Dial Transplant; 1993; 8(5):426-32. PubMed ID: 8393547
[TBL] [Abstract][Full Text] [Related]
20. [Effect of long term prazosin treatment on secretion of insulin, glucagon, gastrin, and pancreatic polypeptide in patients with essential hypertension].
Zukowska-Szczechowska E; Grzeszczak W; Kokot F; Wiecek A
Pol Arch Med Wewn; 1993 Jan; 89(1):38-45. PubMed ID: 8479941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
